Investment
Features
FeesSafety
Academy
More
Pluang+

STERIS to acquire Xodus Medical for $2.1B, expanding surgical safety product line by end of 2026

Company Fundamentals
12 Oct 2026
Na
View Source
Bullish
STERIS to acquire Xodus Medical for $2.1B, expanding surgical safety product line by end of 2026

STERIS plc announced it will acquire Xodus Medical, a specialty surgical products company, for $2.1 billion, with the deal expected to close by December 31, 2026. The acquisition will expand STERIS's healthcare consumables portfolio, particularly in operating room safety products, aligning with its mission to enhance patient and staff safety. Xodus Medical's 2026 projected revenue is $245 million with strong adjusted EBIT, and the deal is expected to boost STERIS's growth, margins, and earnings. Financing will be primarily through debt, with potential earnout payments based on future performance.

STERIS's acquisition of Xodus Medical is notable in the healthcare sector context. For readers following health stocks, here is Pluang's market snapshot as of Oct 12, 2026 18:11 WIB: out of 128 priced US health-sector stocks, 60 rose and 45 fell. Biogen Inc (BIIB) traded at USD 231.33 with a 1-day change of +2.49%, Roivant Sciences Ltd. (ROIV) at USD 34.70 with -2.09%, and Heron Therapeutics Inc (HRTX) at USD 0.41 with +2.07%.

More News

Rezolve AI CFO to discuss AI-driven commerce at Maxim Growth Summit 2026

Rezolve AI CFO to discuss AI-driven commerce at Maxim Growth Summit 2026

Rezolve AI announced that Arthur Yao, their Group CFO, will participate in the Consumer & Lifestyle Panel at the Maxim Growth Summit 2026 on October 13. The panel will focus on the rise of agentic commerce and its effects on consumer and lifestyle se...

Market News
Neutral
14 minutes ago
STMicroelectronics repurchases 346,538 shares worth €17M to support employee share programs

STMicroelectronics repurchases 346,538 shares worth €17M to support employee share programs

STMicroelectronics repurchased 346,538 of its ordinary shares on Euronext Paris between October 5 and 9, 2026, spending about €17 million at an average price of €49.24 per share. This buyback, representing 0.04% of its issued share capital, aims to f...

Company Fundamentals
Neutral
14 minutes ago
Nano Labs schedules 2026 AGM to approve share consolidation, re-designation, and subdivision plans.

Nano Labs schedules 2026 AGM to approve share consolidation, re-designation, and subdivision plans.

Nano Labs Ltd announced its 2026 Annual General Meeting on November 24, 2026, in Hangzhou, China. The meeting will seek shareholder approval for a share consolidation (10-to-1), re-designation of shares into Class A and B, and a conditional share sub...

Company Fundamentals
Neutral
14 minutes ago
Harmony Biosciences appoints Peter Anastasiou as new CEO starting January 2027, with current CEO retiring.

Harmony Biosciences appoints Peter Anastasiou as new CEO starting January 2027, with current CEO retiring.

Harmony Biosciences announced that Peter Anastasiou will become President and CEO effective January 1, 2027, succeeding Jeffrey M. Dayno, who will retire at the end of 2026. Dayno will remain as a non-executive advisor through 2027 to support the com...

Company Fundamentals
Bullish
1 hour ago
St. Louis Blues to air 10 Thursday games on Gray Media's ABC 32 in 2026-27 season

St. Louis Blues to air 10 Thursday games on Gray Media's ABC 32 in 2026-27 season

The St. Louis Blues and Gray Media announced a multi-year deal to broadcast 10 select Thursday games over-the-air on ABC 32 in St. Louis and 10 other markets during the 2026-27 NHL season. This expands access to Blues games for over 4.8 million house...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App